Cigna Group (NYSE:CI) Releases FY 2025 Earnings Guidance

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Cigna Group (NYSE:CI - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 29.600- for the period. The company issued revenue guidance of -.

Cigna Group Stock Performance

Shares of Cigna Group stock traded down $5.12 on Friday, hitting $262.26. The stock had a trading volume of 3,428,214 shares, compared to its average volume of 1,636,711. The company has a quick ratio of 0.72, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock has a market cap of $70.06 billion, a price-to-earnings ratio of 14.32, a price-to-earnings-growth ratio of 0.81 and a beta of 0.47. The business's 50 day moving average is $308.90 and its two-hundred day moving average is $311.92. Cigna Group has a twelve month low of $256.89 and a twelve month high of $370.83.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating the consensus estimate of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same period in the prior year, the company posted $6.72 earnings per share. Cigna Group's revenue was up 11.0% compared to the same quarter last year. Analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be given a $1.51 dividend. The ex-dividend date is Thursday, September 4th. This represents a $6.04 annualized dividend and a dividend yield of 2.3%. Cigna Group's payout ratio is presently 33.44%.

Analyst Ratings Changes

CI has been the subject of several recent analyst reports. Royal Bank Of Canada restated an "outperform" rating and set a $371.00 price objective on shares of Cigna Group in a research report on Thursday, June 26th. Morgan Stanley lifted their price target on shares of Cigna Group from $379.00 to $390.00 and gave the company an "overweight" rating in a report on Monday, May 5th. Barclays cut their target price on shares of Cigna Group from $385.00 to $354.00 and set an "overweight" rating on the stock in a research report on Friday. Cowen reaffirmed a "buy" rating on shares of Cigna Group in a research note on Monday, May 5th. Finally, Mizuho increased their price target on Cigna Group from $360.00 to $384.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Three investment analysts have rated the stock with a hold rating, sixteen have given a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $378.67.

Institutional Investors Weigh In On Cigna Group

An institutional investor recently raised its position in Cigna Group stock. Brighton Jones LLC boosted its position in Cigna Group (NYSE:CI - Free Report) by 9.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,736 shares of the health services provider's stock after buying an additional 318 shares during the period. Brighton Jones LLC's holdings in Cigna Group were worth $1,032,000 at the end of the most recent quarter. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.